1. The chicken chorioallantoic membrane model in biology, medicine and bioengineering

   • Patrycja Nowak-Sliwinska
   • Tatiana Segura
   • M. Luisa Iruela-Arispe

   Review Paper 20 August 2014 Pages: 779 - 804

   

2. The role of antiangiogenic agents in the treatment of patients with advanced colorectal cancer according to K-RAS status

   • Pilar García-Alfonso
   • Enrique Grande
   • Clara Montagut

   Review Paper 03 May 2014 Pages: 805 - 821

   

3. VEGF neutralization can prevent and normalize arteriovenous malformations in an animal model for hereditary hemorrhagic telangiectasia 2

   • Chul Han
   • Se-woon Choe
   • S. Paul Oh

   Brief Communication 24 June 2014 Pages: 823 - 830

   

4. The HIV protease inhibitor indinavir down-regulates the expression of the pro-angiogenic MT1-MMP by human endothelial cells

   • Giovanni Barillari
   • André Iovane
   • Barbara Ensoli

   Brief Communication 10 April 2014 Pages: 831 - 838

   

5. Galectin-1 induces vascular permeability through the neuropilin-1/vascular endothelial growth factor receptor-1 complex

   • Ming-Heng Wu
   • Nien-Wen Ying
   • Yuh-Ling Chen

   Original Paper 10 April 2014 Pages: 839 - 849

   

6. Functional analysis reveals angiogenic potential of human mesenchymal stem cells from Wharton’s jelly in dermal regeneration

   • Sandra S. Edwards
   • Gabriela Zavala
   • Verónica Palma

   Original Paper 13 April 2014 Pages: 851 - 866

   

7. Acidic preconditioning improves the proangiogenic responses of endothelial colony forming cells

   • Hebe A. Mena
   • Anna Lokajczyk
   • Soledad Negrotto

   Original Paper 23 May 2014 Pages: 867 - 879

   

8. Angiopoietin-like 7, a novel pro-angiogenetic factor over-expressed in cancer

   • Matteo Parri
   • Laura Pietrovito
   • Renata Grifantini

   Original Paper 06 June 2014 Pages: 881 - 896

   

9. TM4SF1: a new vascular therapeutic target in cancer

   • Chi-Iou Lin
   • Anne Merley
   • Shou-Ching S. Jaminet

   Original Paper 02 July 2014 Pages: 897 - 907

   

10. Genetic variability of VEGF pathway genes in six randomized phase III trials assessing the addition of bevacizumab to standard therapy

    • Sanne de Haas
    • Paul Delmar
    • Diether Lambrechts

    Original Paper 11 July 2014 Pages: 909 - 920

    

11. Mechanisms of vasculogenesis in 3D fibrin matrices mediated by the interaction of adipose-derived stem cells and endothelial cells

    • Sabrina Rohringer
    • Pablo Hofbauer
    • Wolfgang Holnthoner

    Original Paper 03 August 2014 Pages: 921 - 933

    

12. Developmental Vascular Biology and Genetics Workshop VI and Vascular Inflammation Workshop organized by NAVBO

    ABSTRACTS 24 September 2014 Pages: 935 - 984